Clinical trial
Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers…
NCT00404287 · AORTICA Group, Other · Terminated
Key facts
| NCT number | NCT00404287 |
|---|---|
| Title | Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis. |
| Official title | Double Blind Randomized Phase IV Clinical Trial to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in the Haemodynamic Progression of Degenerative Aortic Stenosis. The AORTICA 1 Study. |
| Lead sponsor | AORTICA Group, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Aortic Valve Stenosis |
| Intervention type | Drug |
| Interventions | Fluvastatin |
| Enrollment | 164 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2014 |
| Completion | Jan 1, 2018 |
| First posted | Nov 28, 2006 |
| Last update posted | Jun 7, 2019 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: